Embed Size (px)
Citation preview
Meeting Report
The Global Fund SEA Constituency Meeting
23-24 April 2018
Venue: Ministry of Health and Family Welfare (MoHFW) and
International Institute of Health Management Research Delhi (IIHMR) New Delhi
Page 1 of 29
Table of contents
Page 2 of 29
Executive Summary 1. Introduction The Global Fund SEA Constituency Meeting was held in New Delhi, 23 -24 April 2018. The meeting was hosted by Ministry of Health and Family Welfare (MoHFW) and sponsored by WHO. Inaugural Session was held in the Ministry of Health and Business Session was arranged in the International Institute of Health Management Research (IIHMR), Delhi. Except for DPR Korea all other member states were represented. The Chief of Staff from GF Secretariat, representative from UNAIDS, PATH and WHO – SEARO also participated. 2. Preparatory Meeting The main meeting was preceded by a preparatory meeting on 22nd April 2018 which was held in IIHMR at 3pm under the chairmanship of Board Member Mr. Filipe Da Costa to review the agenda for the main meeting and to observe the arrangements and organisations of the main meeting. 3. Inaugural Session The Inaugural Session started with welcome address by Dr. K. S. Sachdeva, DDG (NACO)/India CCM Focal Point. The Meeting was inaugurated by Preeti Sudan Hon’ble Secretary of Health and Family Welfare, MoHFW, Government of India. The chief Guest after welcoming all the delegates, dignitaries and guests highlighted that India is having high disease burden of TB, HIV/AIDS and Malaria which means India’s performance has direct influence on the Regional and Global achievements. She also highlighted India’s commitment to reduce the burden of these diseases and fulfil its role in the region. She mentioned that India is both a donor and recipient for the Global Fund. India is the highest donor in the South East Asia Region to the Global Fund at the same time India is also amongst the biggest portfolio with GF investment. She wished all the delegates from the 10 countries a very successful deliberation in the next two days of the meeting. The inaugural session was also addressed by Mr Filipe Da Costa, Board Member, Dr Swarup Sarkar, Director, CDS, WHO/SEARO, Dr. Marijke Wijnroks, Chief of Staff, Global Fund, Mr. Vikas Sheel, Joint Secretary, GFATM. Summary of their addresses are given in the main body of the report and the speeches are annexed in Annexure - III.
The Vote of thanks was offered by Prof. MA Faiz, Alternative Board Member (ABM) from Bangladesh.
4. Business Session After appointing the Office Bearers, the meeting was appraised on the status of the last meeting report held in Bangkok Landmark Hotel 30 -31 October 2017 followed by financial update of the SEA Constituency. Both the updates were noted by the meeting.
The Board member introduced the agenda item on Regional Coordination Mechanism (RCM) by recalling the past discussions in the last two years meeting and also the various decisions to institute RCM and its Secretariat. Concern was expressed of slow progress and proposed for forming an Ad-hoc committee with appointment of members and TOR of the committee in this meeting itself. After deliberating on this proposal, the Constituency meeting decided to form the Ad-hoc committee to take forward the formation and functioning of Regional Coordination Mechanism (RCM) and its secretariat.
4.1 Ad-hoc Committee
Page 3 of 29
The constituency meeting held in Delhi on 23-24 April 2018 decided to form Ad-hoc committee which will start functioning immediately with the following 7 members and ToR. Dr. Jigmi Singay was appointed as the coordinator for the Ad-hoc committee other committee members are Dr Suriya Wongkongkathep, Mr Filipe Da Costa, Dr. Avdhesh Kumar, Mr Abdul Hameed, Prof Dr Mahmudur Rahman and Dr Olavi Elo.
The ToR of this Ad-hoc Committee is as follows:
I. To review the existing regional coordination mechanisms and to build alliance; II. To review the already approved TOR of the RCM and its Secretariat and make it
more relevant to the present context; III. To identify the regional priorities and to develop regional proposals for
submission to the Global Fund and other donors and partners; IV. Ad-hoc committee to collaborate with PATH for logistic and financial support to
initiate the regional coordination mechanism, resource mobilization and formation of Secretariat and also to collaborate with WHO, UNAIDS and others.
4.2. Position Papers The constituency meeting after deliberating on two important issues;
I. Displaced population from Myanmar living in Bangladesh II. Closure of Global Fund grant for TB and Malaria programme in DPR Korea;
Displaced population from Myanmar living in Bangladesh: The Global Fund (GF) SEA Constituency Meeting held on 23 – 24 April 2018 in IIHMR New Delhi having noted very poor living condition of the large number of displaced population from Myanmar living in Bangladesh, and also noting the increasing cases of TB, HIV and Malaria in this displaced population expressed serious concern of their health situation and potential risk of disease outbreaks. The progress made by the Global Fund supported program is already facing challenges with increasing number of cases and there is risk of spreading these diseases to the nearby local population. The Global Fund Board is requested to consider additional allocation to Bangladesh to adequately cover this displaced population so that there is no setback to the ongoing programs. SEA Constituency Position on Global Fund grant closure for TB and Malaria programme in DPR Korea: The Global Fund (GF) SEA Constituency Meeting held on 23 – 24 April 2018 in IIHMR New Delhi having learnt that an executive decision has been made by the Global Fund Secretariat to close the grants for DPR Korea is requesting the GF Secretariat to reconsider the decision as the country has made tremendous progress in reducing the disease burden and mortality from Malaria and TB. The meeting further requests the Board to review the Secretariat decision and in future adequate consultation be carried out with CCM and the government prior to undertaking such decisions.
The position paper on additional funding request for Maldives to end TB in the country
by 2022 will be circulated later upon receipt of the draft from the CCM Maldives (Mr
Abdul Hameed, CCM Focal Point Maldives).
4.3 Adoption of one Decision and two Constituency Positions: The draft report on one constituency decision and two constituency positions has been adopted by the meeting.
Page 4 of 29
4.4. Announcement of election results of Board Member and Alternate Board Member
The following two candidates had been elected as new leader for a period of 2 years i.e. June 2018 to May 2020:
Prof. MA Faiz , from Bangladesh - Board Member (BM) Dasho Kunzang Wangdi, from Bhutan – Alternate Board Member (ABM)
Mr.M K Biswas BCCM Coordinator has been appointed by the incoming Board Member Prof.M A Faiz as Communication Focal Point (CFP) 4.5 Presentations during business session 4.5.1 Regional trend and Situation of TB/HIVAIDS by Dr. Mukta Sharma Regional Advisor, WHO/SEARO. Meeting has noted the concerns such as infections still occurring in key population, younger age groups and adequate resources to scale up the programs has supported the way forward proposals. 4.5.2 Based on the update presentation on three board committee (SC, AFC & EGC) by Dr. Marijke Wijnroks, Chief of Staff, Global Fund Secretariat, task distribution amongst the delegates for intervention during the board meeting has been done accordingly. 4.5.3 An update on Regional Project proposal was done through Skype by consultant Dr. Olavi Elo.
4.5.4 Country updates
The countries shared their experience and status of the TB, HIV/AIDS & Malaria situation in their respective countries. In this meeting the update included the inter country and cross border collaboration also.
4.5.5 A presentation was made by Reeta Bhatia, UNAIDS giving the current profile on HIV/AIDS & TB in Asia pacific Region. The meeting noted the concern of the infection still occurring in key population, population of younger age groups and inadequate resources for program acceleration.
4.5.6 Venue for the next constituency meeting
Myanmar, subject to Government approval has agreed to host the next constituency meeting. MHCC Myanmar will confirm it to the board member at an early date.
Timor Leste subject to confirmation has agreed to be the alternative venue
4.5.7 Participants View
MK Manaj, BCCM Coordinator from Bangladesh expressed that he is fully satisfied with the outcome and the arrangement of the meeting and thanked MOHFW & IIHMR for hosting and WHO for funding it.
Co-Chair expressed his thanks and gratitude to all the participants for electing him as the Board Member and he assured the meeting in putting all the efforts and carrying out his task to the best of his capability.
4.5.8 Vote of thanks
After the offer of vote of thanks by delegate from Maldives, Chairperson of the meeting thanked all the delegates and participants for their active participation and bringing the
Page 5 of 29
meeting to a successful conclusion. He also thanked organizers from the MoHFW and IIHMR Delhi for the excellent arrangement of the meeting.
The Chair formally adjourned the meeting at 1500 HRS.
Page 6 of 29
Meeting Report
1. Introduction Pre-board Global Fund SEA Constituency Meeting was held in New Delhi, 23 -24 April 2018. The meeting was hosted by Ministry of Health and Family Welfare (MOHFW) and sponsored by WHO. Inaugural Session was held in the Ministry of Health and Business Session was arranged in the International Institute of Health Management Research (IIHMR), Delhi. Except for DPR Korea all other member states –Bangladesh, Bhutan, Indonesia, India, Maldives, Myanmar, Nepal, Sri Lanka, Thailand and Timor Leste were represented in the meeting with a total participant of 20 people. The Chief of Staff from GF Secretariat, representative from UNAIDS, PATH and WHO – SEARO also participated.
2. Preparatory Meeting A preparatory meeting for GF SEA Constituency Meeting was held at the IIHMR Delhi on 22nd April 2018 at 3pm. The agenda of the Preparatory meeting was approved. The draft agenda of the main meeting on 23 – 24 April was reviewed and finalized. The proposal for the Office Bearers of the Meeting (Chair, Co-Chair and Rapporteur) was discussed and the names for nomination in the meeting finalised. Secretariat and drafting committee were appointed. A visit to the Meeting venue was done and found facilities to be adequate and arrangements satisfactory. A video screening item on IIHMR family during a lunch time was added to main Agenda. It was then followed by a visit to the Radisson Blue Hotel where all the participants were to be accommodated. And the hotel was found to be very good and the rates reasonable 3. Proceedings of Day I (23rd April 2018)
3.1 Inaugural session (Venue: Ministry of Health & Family Welfare, Govt. of India)
3.1.1. Dr. K.S Sachdeva, DDG (NACO)/ India CCM Focal Point welcomed the Hon’ble Chief Guest, delegates from the GF SEA Constituency Member States, and the partners and dignitaries present in the inaugural sessions. He also highlighted that India is both recipient as well as a donor of the Global Fund. India has high diseases burden in the region and plays an important role in achieving the SDG targets. India is fully committed to fulfil its role.
3.1.2 Mr. Filipe Da Costa, Board Member, Global Fund, in his inaugural address thanked Ministry of Health & Family Welfare, Govt. of India for hosting the Constituency Meeting in India and WHO/SEARO for the generous financial and technical support in conducting the Constituency Meeting. He informed that this GF SEA Constituency meeting will be reviewing the Board Agenda of upcoming Board Meeting and forming the Regional Position on the relevant agenda items to the region. He also mentioned that one of the main agenda item will be deliberation on the Regional Coordination Mechanism (RCM) which has become crucial for the Member States to achieve their elimination targets and SDG Goals. 3.1.3 Dr. Swarup Sarkar, Director- CDS/WHO-SEARO, while welcoming the delegates and thanking the MOHFW, highlighted the fundamental principles of the Global Fund as – partnership, country ownership, performance-based funding, partnership based funding, and transparency, this meeting introduces the delegates to the agendas of upcoming Global Fund thus enabling to arrive at regional response to the agenda points in consultation with delegates and convey the same to the Board Meeting. He further
Page 7 of 29
highlighted that since inception GFS invested over USD 4 billion in the region (52 percent for HIV, 30 percent for TB, 17 percent for Malaria) in the current period of 2017-2019 and USD 1.3 billion in the region except for Maldives. While sharing the success story of Malaria elimination in Sri Lanka and Maldives and noting the other countries moving toward elimination (Bhutan, Timor-Leste and Nepal), the region as a whole has to go a long way to achieve the SDG goals. It was highlighted that in the region funding gaps for TB alone is about USD 1.3 billion each year. It was further highlighted that SEA Constituency Board leadership should support countries which have significantly reduced disease burden to facilitate to reach elimination targets.
3.1.4 Dr. Marijke Wijnroks, Chief of Staff, Global Fund, thanked Hon’ble Secretary of Health, MoHFW for gracing the Inaugural Session as the Chief Guest of this very important meeting and mentioned that the political commitment of India’s Prime Minister Shri. Modi and commitment at all levels to the elimination targets, eg to eliminate TB by 2025 is remarkable. She mentioned that the region is in a good position to eliminate and then shift the needle to Tuberculosis. She underlined the importance and value of Constituency Meeting in preparing to ensure not only good representation in the Board but also the region’s concerns are heard, and insights shared. She also highlighted on the issues and important topics such as revision of the Eligibility Policy, Risk Appetite Framework to guide informed decision making and way forward for CCM Evolution initiative that the Board will consider in the upcoming 39 Board Meeting in Macedonia. She wished the Constituency a very fruitful and successful meeting.
3.1.5 Mr. Vikas Sheel, Joint Secretary, GFTAM, while welcoming the delegates and guests highlighted on the significant strides India has made in curbing the HIV, TB and Malaria burden and shared information on newer initiatives for reducing mortality and morbidity rates of these diseases. He shared information on RNTCP providing quality assured free treatment and diagnosis facility to all TB patients since 1997 and currently serving 2.8 million TB patients (1/4th of global TB burden). NACP has been successful in achieving the MDGs in 2015 in halting and reversing the HIV epidemics with 57 percent decline in HIV incidence and 54 percent reduction in mortality over the last decade. Currently, test and treat all policies 90:90:90 continuum of care strategy are the broad priorities under National Strategic Plan. National Vector Borne Disease Control Programme (NVBDCP) has launched “National Framework for Malaria Elimination (2016-2030)” with the vision for Malaria free India and has adopted prime strategies of: LLIN distribution and IRS spray in high endemic states, strengthening surveillance (HMIS) and enhancing BCC activities etc.
3.1.6 Hon’ble Chief Guest, Ms. Preeti Sudan, extended hearty welcome to all the delegates, guests and officials of the MoHFW. She highlighted that India being the highest burden country for Tuberculosis; second highest for HIV-TB co-infection and third highest for HIV/ AIDS and Malaria, holds unique position of impacting the global health scenario of these diseases and is looked up for its efforts in the line of sustainable development goals. Further highlighted that India is committed to reduce disease burden of HIV/AIDS, Malaria and Tuberculosis and is making progressive move in this direction. India has set target to eliminate TB by 2025, five years ahead of sustainable development goals target and 10 years ahead of WHO End TB target. With the vision for Malaria free India by 2030, National Framework for Malaria Elimination has been launched. India has pledged to end AIDS by 2030 and is on track to eliminate HIV, through its strategic framework of 90:90:90.
She informed the Meeting that the Global Fund has been in a sustained partnership with India since its establishment (2002) in fight against HIV/AIDS, TB and Malaria. India shares donor as well as recipient relationship with the Global Fund. So far, India has contributed around 26.5M USD to the Global Fund as a donor and is the largest donor
Page 8 of 29
within SEA region with its 20M USD pledge towards 5th replenishment (2017-2019) of the Global Fund. India is amongst the biggest portfolios of the Global Fund with around 2 billion USD investment so far. She wished the Constituency Meeting all the best for a productive and meaningful deliberation.
3.1.7 The inaugural session ended with the vote of thanks given by Prof. MA Faiz, ABM, which was then followed by photo session. The Vote of thanks was offered by Prof. MA Faiz, Alternative Board Member (ABM) from Bangladesh. He thanked the Hon’ble Chief Guest for not only gracing the occasion but also highlighting India’s commitment in achieving the elimination targets and setting the tone of the meeting. He thanked the Ministry of Health and Family Welfare for very timely hosting this meeting in short notice. He thanked all the speakers for sharing valuable information and giving guidance to the meeting. He also thanked WHO for the continued financial and technical support received in organizing SEA GF Constituency Meeting. And thanked all the delegates from the Member States, other partners- UNAIDS and PATH, and the organizers of the function and all others attending this Inaugural Ceremony of the GF SEA Constituency Meeting held in Delhi.
3.2 Business session (Venue: IIHMR Delhi)
3.2.1 Appointment of the Office Bearers Mr. Filipe Da Costa, Board Member, invited nomination for the Chairperson, Co-Chair and Rapporteur. The following were elected as office bearers for the meeting:
Chairperson: Dr. KS Sachdeva, DDG (NACO)/India CCM Focal Point Co-Chair: Prof. MA Faiz, Vice Chair, BCCM Rapporteur: Dr. Karma Lhazeen, Director, Department of Public Health/CCM
Member, Bhutan 3.2.2 Update of the last meeting minutes Dr. Jigmi Singay, Consultant for SEA Constituency Meeting, updated on the two days SEA GF Pre-Board Constituency Meeting held in the Landmark Hotel, Bangkok, 30 – 31 October 2017 under the Chairmanship of Dr Janaka Sugathadasa, Secretary MoH&N and CCM Chairperson of Sri Lanka. 10 out of 11 Member States participated along with Ms. Aida Kurtovic, Chair of the Global Fund and Dr Carole Presern, Director, OBA, 2 participants from UNAIDS and Ms. Ida Hakizinka, Executive Director, Aidspan participated in this meeting. The draft report was submitted during the closing session by Rapporteur Dr. Rai Mra from Myanmar.
The final report with amendments from Bangladesh was circulated on 5th December 2017. The report of the meeting is attached as one of the reference document in this meeting.
3.2.3 SEA constituency financial update and work plan Mr. Noe Gasper Pinto Da Silva, Interim Communication Focal Point (CFP) presented the
SEA constituency financial updates. During 2016, US$ 7,000.00 was allocated and the
total amount was utilized. In 2017, US$ 100,000.00 was allocated and US$ 98,803.00
was spent. In total, across these two years, US$ 105,000.00 was allocated to SEA and
US$ 103,803.00 was spent. In year 2018, a total of US$ 100,000.00 is allocated (US$
98,803.00 – 2018 allocation plus US$ 1, 197.00 – 2017 balance). Funded work plan for
year 2018 was shared by CFP with following outcome, activities and funds is given
below:
Page 9 of 29
Target Outcome Activities Amount (US$)
Increase Constituency Engagement at the Governance Meetings
Additional constituency member to attend Board Meeting
40,000.00
Ensure issues and challenges be presented at the board meeting
Conducting SEA constituency meeting to discuss progress and challenges
40,000.00
Understanding issues and progress of GF implementation among SEA countries which will be shared at the GF Governance forum for improve GF engagements.
Un-funded work plan for year 2018 was shared by CFP with following outcome and
activities:
Target Outcome Activities
Improved Regional Cooperation Cross border and multi-country programs concept note on Malaria Elimination and TB/HIV prevention
Submission of Regional Concept Note on Malaria, TB/HIV developed
Develop Regional Concept Note in Malaria, TB/HIV
Regional Grant Making SEA decision on Regional Grant Making
Regional Grant Oversight Each SEA member countries conduct oversight activities
Produce Annual Progress update SEA Retreat on annual progress and challenges
3.2.4 Briefing on Regional Coordination Mechanism (RCM) Board Member highlighted the past discussions on the Regional Coordination
Mechanism in the successive meetings starting from Yogyakarta to Dilli, Timor-Leste.
3.2.4.1 Setting up of Ad–hoc committee:
He proposed to set up an Ad-hoc Committee with following tasks:
Start the process for resource mobilisation for the RCM secretariat and RCM
meetings
To set up the RCM, the secretariat and the member of RCM
Start Facilitate process for regional program design.
3.2.4.2 Ad-hoc Committee Members
He suggested following names for the ad-hoc committee to the Constituency:
Mr. Hameed, who is the initial drafter of the RCM concept
Dr. Olavi who have started putting together ideas on the regional programs
Dr. Jigmi who have been supporting the idea and bring it to all levels of
discussion
Dr. Suriya who is one of the senior member of the constituency and have
been active also on the RCM discussion
Dr. Filipe Da Costa, as suggested by Prof. Faiz
Page 10 of 29
BM appraised the meeting about the organization - Program for Appropriate
Technology for Health (PATH) and their interest to collaborate and support the RCM
and its secretariat till it is well instituted through Global Fund and other Funding
sources called upon the PATH Country Director Mr Neeraj Jain to address the meeting.
Country Director of PATH Mr Neeraj Jain confirmed their interest to support the
development of RCM and its Secretariat through logistic and financial support to the Ad-
hoc Committee in project proposal development for submission to GF and other donors
and basic minimum staff and space, and resource mobilization through providing the
logistic and financial support to the Ad-hoc Committee and its secretariat formation and
functioning till such time RCM is able to mobilize its own resources and funding from GF
and other donors.
UNAIDS also offered TA assistance in the area of project proposal development and
other technical HR requirements.
During the discussion, Ms. Marijke informed about the two-existing regional program in
the region, TB and Artemisinin drug Resistance and their coordination. It was
mentioned that National CCM needs to be involved and fully aware of any such regional
program and their coordination mechanism. Dr Suriya who is current RCM member of
Drug Resistance Mekong Region Program shared information on the functioning of
RCM. It was also shared that too many regional mechanisms is not effective since same
people are attending different regional meetings of different regional programmes.
3.2.5 SEA Regional trends and situation of TB, HIV/AIDS updates
Dr Mukta Sharma, RA HIV TB HEP, WHO SEARO, presented the regional trends and
situation of HIV and TB in SEAR.
HIV/AIDS continues to be a major public health problem in the region. Approximately,
10% of all PLHIV live in SEAR, an estimated 3.5 million, of these 39% are females. The
99% of these 3.5 million are in five countries, India, Indonesia, Myanmar, Nepal and
Thailand. The epidemic is concentrated among key populations in most countries of
SEA. The two thirds of the new infections are still occurring in key populations.
South-East Asia Regional HIV Action Plan 2017-2021was presented. The vision of this
action plan is to have zero new infections, zero HIV-related deaths and zero
discrimination. The goal of the action plan is to end the AIDS epidemic by 2030. The
SEAR fast track targets is that by 2020 achieve reduction in new infections by 72%;
reduction in HIV-related deaths by 67%; and double the numbers of person on life-
saving antiretroviral.
Considering the issues/challenges faced by countries in the region it is likely to miss
these targets and goals. In order to accelerate the programme, the following activities
are proposed by WHO/SEARO:
Identify high risk communities, geographically and key populations; Design impact
interventions, engaging communities to be part of the response; Front-load
investment, especially on testing, diagnosis, and linkage to care; Create an enabling
environment – Zero discrimination in laws, regulations, policies, and especially in
Page 11 of 29
the health sector; and Strengthen information systems – progress needs to be
monitored at local level
It was highlighted that SEA Region bears ~ half the global burden of TB disease. In
terms of SEA program performance, gap is closing between case notification and
incidence, yet ~ 2 million are missing; and there is worrying decline in treatment
success of DS-TB cases. She presented about regional effort undertaken so far – for
instance, Delhi Call for Action, 2017; and Statement of Action, 2018.
In order to accelerate the programme, it is suggested that Partners and Donors need to
Front load and scale up investments in high burden countries to cover current financing
gaps; Establish financing channels for innovations; Define non-health elements of
interventions and standardize unit costs; and Innovation to Implementation (I2I) fund
that would support innovation. The presentation is annexed.
3.2.6 Malaria elimination and cross border collaboration update
Dr. Avdhesh Kumar, Additional Director, National Vector Borne Diseases Control
Programme, MoHFW, Government of India pointed out that India, Bangladesh &
Myanmar are high endemic countries; Nepal medium endemic and Bhutan low endemic
country among SEA.
Border areas are highly malaria endemic and require cross-cutting intervention. Cross-
border collaboration is critical. He highlighted that there are 70 districts, spread across
12 states, bordering Bhutan, Nepal, Bangladesh and Myanmar, and covers 115 million
population.
He presented the National Strategic Plan 2017-2022 and following strategies for cross-
border collaborations:
Screening of population; training of security personnel; Dx & Tt facilities; data collection
and its integration into national MIS; sharing of information & policy guidelines; joint
planning and implementation of malaria prevention & control activities; and regular
review meetings. Crucial role of financial support and coordination mechanism for
cross-border collaboration.
Three main challenges were highlighted: Political, Technical and Financial
As a way forward, he pointed out that a joint action plan for (i) reducing importation
risk on both sides, which requires strong surveillance system; (ii) vector control that
help in reducing vector load; (iii) EWS & rapid response team; (iv) information sharing;
(v) joint annual evaluation/review by bordering nations; (vi) inter-country meeting of
bordering nations; (vii) state/district level inter-country meeting; (viii) GF support for
regional cross-border collaboration proposal; (ix) utilization of saving from GF grants
(Presentation Annex VI)
3.2.7 GF Secretariat and three committees (SC, AFC & EGC) of the Board update:
Dr. Marijke Wijnroks, Chief of Staff, Global Fund, presented the following
recommendation to the Board by the Ethics and Governance Committee:
Page 12 of 29
(i) CCM Evolution and CCM code of Conduct; (ii) Strengthening the Board
Leadership Selection Process; (iii) Initial Review Committee Membership
Appointments 2018-2020 term (Board Leadership recommendation)
It was then followed by presentation on the information or input required for
implementing the recommendation.
Following recommendation to the Board by the Strategy Committee were presented:
(i) Agree on Risk Appetite Statements; (ii) Revised Eligibility Policy; (iii) Evolving
CCMs to Align with the Global Fund Strategy; (iv) Potential Engagement with
Non-Eligible Countries in Crisis and then presented the information or inputs
required.
Dr. Marijke Wijnroks shared the following agenda items to the Board for Audit &
Finance Committee:
(i) 2017 Annual Financial Report and statutory Financial Statements; (ii)
Risk Appetite Framework; (iii) Performance Target for KPI 12B (EDP
closing before the Board meeting)
(Presentation Annex V)
3.2.8 Regional project proposal and way forward (presentation was made over the Skype Call)
Dr. Olavi through Skype call thanked the organizers and expressed the hope that the
meeting will result in agreeing to identify the priorities for development of a work plan
and roadmap for RCM, identifying the gaps and needs of the countries and how regional
initiative can help intensify prevention and response to TB, HIV, Malaria and
HSS/CSS/PPP in the region, particularly in the migration and mobility context. He made
a reference to the EOI, which was developed 3 years ago, and mentioned that it needs to
be updated and rethought on its scope. He mentioned that countries and region has
progressed but still has challenges like TB in many countries, HIV (and hepatitis) in
certain key populations. He highlighted that Malaria is an issue in the border areas and
also there is a need to prevent reintroduction of malaria. He mentioned that the
discussion will lead to identification of country challenges, gaps and needs in migration
and mobility context, suggestions on what to include in NSPs to address cross-border
issues (harmonization of protocols, provision of services, information sharing,
coordination, KPs and mobile/migrant labour, refugees, geolocations, resources, TA,
sustainability etc.).
3.2.9 39th Board Meeting Agenda discussion and presentation on decision points of SEA Constituency Position:
The BM introduced the agenda for the 39th Board Meeting which will be held in Skopje,
Macedonia, 6-10 May 2018. He informed the Meeting that besides BM, ABM and CFP, the
following 6 representatives from the countries and one consultant will be attending the
Board Meeting:
Manaj Kumar Biswas (Bangladesh)
Dr Karma Lhazeen (Bhutan)
Mr. Abdul Hameed (Maldives)
Page 13 of 29
Dr. Pushpa Choudhary (Nepal)
Dr. R.R.M.L.R Syambalagoda (Sri Lanka)
Dr. Suriya Wongkongkathep (Thailand)
Dr. Jigmi Singay
On 9th, the following team from the SEA Constituency will be attending the meeting in the Board Room along with the Board Member:
Filipe Da Costa (BM)
Dr Karma Lhazeen (Bhutan)
Mr. Abdul Hameed (Maldives)
Dr. Pushpa Choudhary (Nepal)
Dr. Jigmi Singay
On 10th May, the team will be:
Prof. Dr. M A Faiz (ABM)
Mr. Noe Gasper Pinto Da Silva
Manaj Kumar Biswas (Bangladesh),
Dr. R.R.M.L.R Syambalagoda (Sri Lanka)
Dr. Suriya Wongkongkathep (Thailand)
Each member of the delegation was assigned the following responsibilities:
a. Filipe Da Costa (BM) and Prof. Dr. M A Faiz (ABM) - attend Strategy Implementation Session
b. Dr. R.R.M.L.R Syambalagoda (Sri Lanka) - attend session on Annual Report on Community, Rights and Gender
c. Dr Karma Lhazeen (Bhutan) – attend eligibility policy
d. Mr. Abdul Hameed (Maldives) - update on innovative financing
e. Manaj Kumar Biswas (Bangladesh) - update on TERG
f. Dr. Pushpa Choudhary (Nepal) - risk appetite framework
4. Proceedings of Day II (24th April 2018, Venue: IIHMR Delhi) Day 2 started with recollection and reflection of day – 1 by Alternate board member
Prof MA Faiz and expressed his satisfaction on the deliberation of the agenda items and
appreciated active participation by the delegates.
4.1 Country Updates and Cross Border Collaboration Activities Following countries shared the updates on status of Malaria, HIV and TB in their respective
countries and activities undertaken: Bangladesh, Bhutan, India, Indonesia, Maldives,
Myanmar, Nepal, Sri Lanka, Thailand and Timor Leste. The respective country updates
are in the Annexure VI.
4.2 UNAIDS Presentation
Page 14 of 29
Reeta Bhatia, UNAIDS Asia Pacific office, delivered the attached presentation on some
of the critical HIV/AIDS issues in Asia Pacific region including the significant increase
in new HIV infections in MSM (1 in 4) and young people aged 15-24 (1 in 3); the
present HIV prevention and treatment gap; the double disease burden of Tb-HIV in the
region (63% of people with TB-HIV co-infection do not know their status); the
remaining legal barriers to HIV response in 38 UN Member States in Asia Pacific, and
the present HIV related resource availability and resource needs in Asia Pacific.
Presentation Annexure VII.
4.3 Introduction of new GF SEA Leadership
Out of 11 countries 10 countries (all SEA countries except DPRK) participated in
the election.
The results: The following two candidates had been elected as new leader for a
period of 2 years i.e. June 2018 to May 2020
a. Prof MA Faiz – Board Member (BM)
b. Dasho Kunzang Wangdi – ABM
4.4 Position Papers
The meeting deliberated on 2 proposed position papers i.e. displaced population from
Myanmar in Bangladesh and closure of Global Fund Grant for TB and Malaria
programme in DPRK. The meeting decided to submit two position papers to the Board.
4.4.1 Displaced population from Myanmar to Bangladesh
Position paper on displayed population from Myanmar to Bangladesh to be focused on
health and humanitarian ground and Global Fund 3 disease specific and to request
Board for additional fund allocation to cover the displaced population.
4.4.2 GF Grant closure for Malaria and TB in DPR Korea
The meeting decided to request GF Secretariat to reconsider the decision and Board to
review the decision made by the Secretariat.
4.4.3 Decision
The meeting decided to form an ad-hoc committee and appointed its members with its terms of reference. The meeting further decided that this ad-hoc committee should meet most of the time through Skype conference and only meet when essentially required. Since PATH has expressed interest to collaborate through extending logistic and financial support to ad-hoc committee, establishment of Secretariat and for resource mobilization the meeting endorsed Ad-hoc committee to collaborate with PATH. 4.5 Closing Sessions 4.5.1 Presentation of meeting report by the Rapporteur, Dr Karma Lhazeen : The Secretariat of the meeting informed that the complete report will be sent through email to the individual delegates and participants within this week itself. So Rapporteur was requested to submit only the draft position papers, one decision on formation of the
Page 15 of 29
adhoc committee for the regional coordination mechanism with its members and ToR and the results of the SEA Constituency leadership election. 4.5.2 Rapporteur first presented outline of the final report as follows:
Rapporteur first presented outline of the final report as follows:
– Table of Content – Executive Summary with decisions and constituency positions – Main body of the report as per agenda with annexure agenda of the
meeting, list of participants and speeches of the inaugural session – Separate Annexure document with country update and presentations
4.5.3 Decision of Ad-hoc Committee
Based on the series of discussions held on regional coordination mechanism (RCM) and
Secretariat in the past and having further deliberated in the Delhi constituency meeting,
reinforced by the India’s presentation on Cross Border Collaboration update the
meeting decides to constitute an Ad-hoc committee comprising of following members:
1. Mr. Hameed 2. Dr. Olavi 3. Dr. Jigmi Singay 4. Dr. Suriya 5. Mr Filipe 6. Dr. Avdhesh Kumar 7. Prof Dr Mahmudur Rahman
Ad-hoc committee ToR:
I. To review the existing regional coordination mechanisms and to build alliance ;
II. To review the already approved TOR of the RCM and its Secretariat and make it
more relevant to the present context;
III. To identify the regional priorities and to develop regional proposals for
submission to the Global Fund and other donors and partners;
IV. Ad-hoc committee to collaborate with PATH for logistic and financial support to
initiate the regional coordination mechanism, resource mobilization and
formation of Secretariat and also to collaborate with WHO,UNAIDS and others.
During the discussions the meeting appointed Dr Jigmi Singay as the Coordinator for the
Ad-hoc Committee.
4.5.4 Position Paper
4.5.4.1 Position paper for the displaced population from Myanmar to Bangladesh:
The Global Fund (GF) SEA Constituency Meeting held on 23 – 24 April 2018 in IIHMR
New Delhi having noted the very poor living condition of the large number of displaced
population from Myanmar living in Bangladesh, expressed serious concern of their
health situation and potential risk of disease outbreaks. The progress made by the
Global Fund supported program is already facing challenges as more cases are being
reported among these displaced population. The Global Fund Board is requested to
Page 16 of 29
consider additional allocation to Bangladesh to adequately cover the additional
displaced population so that there is no setback to the ongoing programs.
4.5.4.2 Position Paper on closure of GF grant for Malaria and TB in DPR Korea
The Global Fund (GF) SEA Constituency Meeting held on 23 – 24 April 2018 in IIHMR
New Delhi having learned that an executive decision has been made by the Global Fund
Secretariat to discontinue the grants for DPR Korea. The SEA constituency requests the
Secretariat to reconsider the decision as the country has made tremendous progress in
reducing the disease burden and mortality from Malaria and TB. The meeting further
requests the Board to review the Secretariat decision and in future National CCMs to be
consulted prior to undertaking such decisions.
4.5.4.3 The meeting was informed that Maldives have started implementing the target
of ending TB by 2022 but is facing resource gap by about 6-7M and requested for
support of the Constituency for consideration of allocation from the Global Fund under
the regional mechanism.
4.5.5 Adoption of the draft report
The format of the report, Result of election for the new Board Member (BM) and
Alternate Board Member (ABM), one decision point and two Constituency Positions
presented by Rapporteur Dr Karma Lhazeen, Delegate from Bhutan was adopted by the
meeting with the amendment, Mr M K Manaj BCCM from Bangladesh appointed as
Communication Focal Point (CFP) by the incoming BM and Dr Jigmi Singay as the
Coordinator for the Ad-hoc Committee appointed by the Constituency Meeting.
4.5.6 Views expressed by the participants
Board Member thanked the Government of India particularly MoHFW for hosting this
constituency meeting in a very short notice and thanked all the partners for their active
participation in this meeting, particularly WHO for the continued financial and technical
support. He also thanked IIHMR Delhi for hosting the business session of this meeting.
He thanked all the delegates and the member countries for all the help and cooperation
extend to him during his two-year tenure as board member and he welcomed the new
SEA Constituency leadership as requested to extend same level of cooperation.
Two more delegates Co-Chair and BCCM Coordinator expressed their full satisfaction
with the outcome of the meeting and commended the host country, MoHFW in
particular for the excellent arrangements of the meeting, personal care given to all
delegates and congratulated IIHMR Delhi for participating in hosting this meeting.
4.5.7 Vote of thanks
On behalf of all the participants delegates from Maldives offered vote of thanks. Mr.
Abdul Hameed thank the Government of India and Ministry of Health and Family
Welfare for hosting the SEA Constituency Meeting in short notice. He particularly
thanked Hon’ble Health Secretary Ms Preeti Sudan Hon’ble Secretary of Health and
Family Welfare for graciously inaugurating the constituency meeting and setting the
tone and direction of the meeting. He thanked WHO – SEARO, regional Director, Dr
Swarup Sarkar and his team for the continued financial support for the constituency
Page 17 of 29
meeting and requested to continue the same with the new constituency leadership. He
thanked the Hon’ble Chairperson and Vice Chair for their excellent conduct of the
meeting and ensuring fruitful outcome. He also offered thanks to Dr Marijke Wijnroks,
Chief of Staff, GF Secretariat for her updates, active participation and guidance rendered
to the meeting. He acknowledged the outstanding contribution and leadership of the
outgoing board member and welcome the new leadership of the constituency. While
thanking all the participants for their active participation and successful outcome of the
meeting. He thanked IIHMR for the excellent and very good secretarial work done for
the meeting. He also thanked the participation of WHO, UNAIDS and PATH for their
valuable contribution to the success of the meeting. He once again thanked Ministry of
Health and Family Welfare, Government of India for successfully hosting this meeting.
Chairperson thanked Board Member Mr Filipe for giving India an opportunity to host
this meeting and thanked all the delegates for their active participation and thanked all
the ministerial staff and IIHMR Delhi who were involved in organizing this meeting and
enabling this meeting to a successful conclusion.
The Chair formally adjourned the meeting at 1500HRS.
Page 18 of 29
Annexure I: Agenda
GF SEA Constituency Meeting, 23-24 April 2018
The Global Fund (GF) South-East Asia (SEA) Constituency Meeting,
23-24 April 2018
REVISED TENTATIVE AGENDA
22 APR 2018
- Arrival of Participants and check in the hotel - Preparatory Meeting (Venue: IIHMR, Delhi, 15:00 – 17:00)
India CCM, BM, ABM, CFP and Consultant of the meeting – under the chairmanship of BM
23 APR 2018
08:00 depart from hotel to MoHFW
INAUGURAL SESSION
(Venue: MoHFW)
10:00 – 10:05 Welcome Address by DDG & India CCM Focal point 10:05 – 10:15 Address by Mr. Filipe Da Costa, Board Member 10:15 – 10:20 Address by Dr. Swarup Sarkar, Director – CDS/WHO- SEARO 10:20 - 10:30 Address byDr. Marijke Wijnroks Chief of Staff, Global Fund 10:30 – 10:35 Address by Mr. VikasSheel, JS (GFATM) 10:35 - 10:45 Address by Mr. Manoj Jhalani, AS & MD (NHM)/ Member Secretary, India
CCM 10:45 – 10:55 Inaugural address by Chief Guest – Hon’ble Secretary of Health, MoHFW 10:55 - 11:05 Vote of thanks by Prof. M.A. Faiz Alternate Board Member 11:05 – 11:15 Photo Session 11:30 Departure for IIHMR, Dwarka, New Delhi
REGISTRATION & BUSINESS SESSION
(Venue: IIHMR Delhi)
12:30 onwards – Registration
13.00 – 14.00 Lunch Break
14:00 – 14:10 Nomination of Chairperson, Co-Chair and Rapporteur by BM 14:10 – 14:15 Update of the last meeting minutes by Dr. Jigmi Singay 14:15 – 14:25 SEA constituency Financial update and work plan presentation by CFP 14:25 – 14:35 Briefing on Regional CCM by BM 14:35 – 15:10 SEA Regional trends and situation of TB, HIV/AIDS updates by
WHO/SEARO 15:10 – 15:35 Malaria Elimination and Cross Border Collaboration Update by
WHO/SEARO and Country updates from India 15:35 – 16:00 Secretariat and Three Committees (SC, AFC & EGC) of the Board update by
Page 19 of 29
Dr.MarijkeWijnroksChief ofStaff, GF 16:00 – 16:15 16:15 – 16:30
Tea/Coffee Break Regional Project Proposal and way forward by Dr Olavi Elo, Consultant
16:30 – 17:00 GF 39th Board Meeting Agenda discussion and presentation on decision points of SEA Constituency Position
24 APR 2018 (Venue: IIHMR Dwarka, New Delhi)
08:30 – 08:45 Recollection and reflection of Day 1 by ABM 08:45 – 10:00 Country updates - each country 05 minutes; the following countries –
Bangladesh, Bhutan, Indonesia, Myanmar, Nepal, Thailand and Timor Leste; will also highlight the cross-border collaboration activities in their country updates
10:00 –10:15 Coffee Break 10:15 – 10:30 Introduction of the new SEA Leadership 10:30 – 12:30 Preparation of draft report by Rapporteurs 12:30 – 13:30 Lunch 13:30 - 14:30 Closing Session:
1. Draft Report and Recommendation Presentation by Rapporteur
2. Adoption of the draft report and Recommendations 3. Next venue of the Constituency Meeting 4. Participants Views and Comments 5. Chairperson’s Closing Remark 6. Vote of Thanks 7. Adjournment of the Meeting
Page 20 of 29
Annexure II: List of Participants
GFSEA Constituency Meeting, 23-24 April 2018
SEA Constituency Meeting 23-24 April 2018, IIHMR, New Delhi, India Sl. No. Country Participant Name Designation
1 Bangladesh
Prof. Dr. M A Faiz ABM from SEA Constituency/Vice Chair BCCM
2 Manaj Kumar
Biswas BCCM Coordinator [email protected]
m
3 Bhutan
Dr Karma Lhazeen Director, Department of Pubmic Health/ CCM Member
4 Ms.Suneeta
Chhetri CCM Coordinator
7 Indonesia
Dr. Donald Pardede
MPPM - Chairperson, CCM Indonesia
8 Samhari
Baswedan Executive Secretary, CCM
Indonesia [email protected]
9 Maldives
Mr. Abdul Hameed CCM Focal Point Maldives [email protected]
10 Mr. Ilyas Mohamed CCM Member [email protected]
11 Myanmar
Dr Rai Mra Vice Chair of Myanmar Health Sector Coordination Mechanism
(MHSCC) [email protected]
12 Dr. Thandar Lwin DDG of Disease Control [email protected]
13 Nepal
Mr Achut Sitaula CCM Nepal Vice Chair [email protected]
14 Mr Bhakta Raj
Joshi CCMN Oversight Vice Chair
15 Sri Lanka
DR. R.R.M.L.R Syambalagoda
CCM Sri Lanka Secretary [email protected]
16 Thailand
Dr. Suriya Wongkongkathep
Vice Chair [email protected]
17 Timor-Leste
Mrs. Judith Dias Ximenes
CCM Chair [email protected]
18 Mrs. Merita de Jesus Marques
CCM Oversight Committee [email protected]
19
India
Mr. Vikas Sheel JS(GFATM) [email protected]
20 Dr. K . S. Sachdeva DDG (NACO)/ India CCM Focal
Point [email protected]
21 Dr. Benu Bhatia Programme Officer, India CCM
Secretariat [email protected]
22 WHO
Dr.P.P.Mandal T.O.-TB /WHO SEARO Cum GF Coordinator
23 Global Fund
Dr. Marijke Wijnroks
Chief of Staff, The Global Fund [email protected]
24 UNAIDS
Reeta Bhatia Senior Policy Advisor, UNAIDS Asia Pacific
25 PATH
Mr Neeraj Jain Country Director of India, PATH [email protected]
26 Dr Arvind Betigeri Project Leader, PATH [email protected]
27 Consultants
Dr Olavi Elo Consultant for SEA Constituency Regional Project Proposal
28 Dr Jigmi Singay Consultant for SEA Constituency
Meeting [email protected]
29 Constituency Office Bearers
Filipe Da Costa Board Member, (BM) [email protected]
30 Prof. Dr. M A Faiz, Alternate Board Member, (ABM) [email protected]
31 Noe Gasper Pinto
Da Silva, Interim Communication Focal
Point (CFP) [email protected]
Page 21 of 29
Annexure III: Inaugural Speeches
GF SEA Constituency Meeting, 23-24 April 2018
Ministry of Health & Family Welfare
Address note for JS (GFATM)
Inaugural of SEA constituency Meeting 23rd April, 2018, Nirman Bhawan
10.00-11.30 AM
All the delegates and officials of the ministries of health and CCM from
Bangladesh, Bhutan, DPR Korea, India, Indonesia, Maldives, Myanmar,
Nepal, Sri Lanka, Timor Leste and Thailand on behalf of India CCM, , I
welcome you all to the two days SEA constituency meeting to be held in
New Delhi.
India is making significant strides in curbing the HIV, Tuberculosis and
Malaria burden. MoHFW is working diligently to improvise the several
ongoing national programmes and have added newer initiatives for
reducing mortality and morbidity rates of these diseases.
Let me share with you newer initiatives under national programme for TB,
HIV and Malaria:
TB: Revised National Tuberculosis Control Programme (RNTCP) is
providing quality assured free treatment and diagnostics services to all TB
patients since 1997 and is currently serving 2.8 Million TB patients (1/4th
of the Global TB Burden). To bring in major change in TB scenario of our
country, we have committed to eliminate TB by 2025, five years ahead of
sustainable development goal. National Strategic Plan 2017-2025 has been
developed to eliminate TB by 2025. Launch of active case finding campaign,
introducing 1135 CBNAAT covering all districts, introducing fixed dose
regimen to enhance adherence, Private sector engagement to increase
notification and starting financial incentives (Rs. 500/per patient per
month) for all TB patients are some of the strategies to strengthen the
existing response against TB.
HIV/AIDS: National AIDS Control Programme has been successful in
achieving millennium development goals (MDG) in 2015 of halting and
reversing the HIV epidemic. There has been 67% decline in HIV incidence
over last decade with 54 % reduction in mortality due to AIDS. India is
providing treatment to more than 1.3 Million People Living with HIV
(PLHIV), making it 2nd largest ART provider in the world. India has now
pledged to end AIDS by 2030 and has launched National Strategic Plan for
HIV/AIDS & STI (2017-2024) in this direction. Test and treat all policy and
90:90:90 continuum of care strategy are the broad priorities under NSP.
Page 22 of 29
Malaria: National Vector Borne Disease Control Programme (NVBDCP) has
launched “National Framework for Malaria Elimination (2016-2030)” with
the vision for Malaria free India and has adopted prime strategies of: LLIN
distribution and IRS spray in high endemic states, strengthening
surveillance (HMIS) and enhancing BCC activities etc
India Country Coordination Mechanism (CCM) is the supreme body to
govern, guide and oversee the Global Fund grants and is highly committed
to strengthen measures to fight HIV/AIDS, TB and Malaria in India through
multi-sectoral coordination and effective and inclusive dialogue among
stakeholders. India CCM is a 26 member body of multiple stakeholders with
balanced representation from Government constituency (Centre and State),
Civil Society Organizations, Key affected populations, People affected with
disease, Private sector and Bilateral and Multilateral development partners.
Recently, India has been allocated HIV/AIDS, TB and Malaria grant of 500
MUSD for period 2018-2021 by the Global Fund under the valued
leadership of India CCM.
The Country level efforts for HIV/ TB and Malaria and role of CCM can
further be deliberated at the platform of SEA constituency meeting.
I wish the best of deliberations amongst SEA constituency members and am
very much interested in its outcome, the direction we would take in the
coming year.
Page 23 of 29
Address Note for Secretary (HFW)/ Chair, India CCM
Inaugural session of SEA constituency Meeting 23rd April 2018, Nirman Bhawan
10.00-11.30 AM
Ladies and gentleman,
It is my pleasure to welcome all the delegates and officials of the ministries
of health and CCM from Bangladesh, Bhutan, DPR Korea, India, Indonesia,
Maldives, Myanmar, Nepal, Sri Lanka, Timor Leste and Thailand on behalf
of India CCM to the SEA constituency meeting to be held today and
tomorrow in New Delhi.
India being the highest burden country for Tuberculosis; second highest for
HIV-TB co-infection and third highest for HIV/ AIDS and Malaria, holds
unique position of impacting the global health scenario of these diseases
and is looked up for its efforts in the line of sustainable development goals.
Overall, SEA region has achieved decline in morbidity and mortality related
to HIV/AIDS, TB and Malaria in the last decade, still these diseases pose
serious problem in the region. SEA region accounts for 41% of new TB
cases globally, 10 % of global malaria cases and close to 10% of annual new
HIV cases globally. India bears highest burden of all these diseases within
SEA region. India alone has 1/4th of the global TB cases and contributes to
70 % of confirmed malaria cases of the SEA region. Therefore in context of
the South East Asia region, India holds high significance for its potential to
influence disease situation in its neighboring countries and its success in
combating these disease is quintessential for accomplishing success in SEA
region.
India is committed to reduce disease burden of HIV/AIDS, Malaria and
Tuberculosis and is making progressive move in this direction. India has
set target to eliminate TB by 2025, five years ahead of sustainable
development goals target and 10 years ahead of WHO End TB target. With
the vision for Malaria free India by 2030, National Framework for Malaria
Elimination has been launched. India has pledged to end AIDS by 2030 and
is on track to eliminate HIV, through its strategic framework of 90:90:90.
The Global Fund has been in a sustained partnership with India since its
establishment (2002) in fight against HIV/AIDS, TB and Malaria. India
shares donor as well as recipient relationship with the Global Fund. So far,
Page 24 of 29
India has contributed around 26.5 MUSD to the Global Fund as a donor and
is the largest donor within SEA region with its 20 MUSD pledge towards 5th
replenishment (2017-2019) of the Global Fund. India is amongst the
biggest portfolios of the Global Fund with around 2 billion USD investment
so far.
Considering India’s high disease burden and its position in steering overall
SEA region response to HIV/AIDS, TB and Malaria, enhanced support of the
Global Fund is necessary. India shall be well represented at important
Global Fund platforms, boards and committees. To reinforce India’s
response for these diseases, India shall be well represented at important
Global Fund platforms, board and committees. There is a clear merit in this
for SEA region as well.
One of the other contributions from the Global Fund is its mandate of
structuring Country Coordinating Mechanism (CCM). India has a strong and
dynamic Country Coordination Mechanism which provides platform to
integrate multiple stakeholders from government, academia, civil society,
development partners, multiple, bilateral agencies, vulnerable populations
and people living with HIV/ AIDS, Tuberculosis and Malaria. It is a unique
forum where voices from patients, communities and vulnerable population
are heard and integrated into national response to diseases.
This meeting of SEA constituency which engages CCMs of 11 participant
countries promises to provide a great platform for sharing programme
learnings related to HIV/AIDS, Malaria and TB and to deliberate Global
Fund matters.
I wish all the best for the productive and meaningful deliberations ahead
during the meeting.
Page 25 of 29
Talking points for Dr Swarup Sarkar, CDS, WHO - SEARO Inaugural session of SEA constituency Meeting
23rd April 2018, Nirman Bhawan
– Respected Preeti Sudan Secretary Health, Govt of India
– Manoj Jhalani, Additional Secretory and Mission Director
– Vikas Sheel, Joint Secretary
– Mr. Filipe da Costa, Board Member
– Mr. Serajul Huq Khan, Alternate Board Member
– Respected Country delegates and friends
The Global Fund Board Mechanism is a unique mechanism that
brings diverse stakeholders in the fight against TB, HIV and Malaria
on a single platform.
The fundamental Principles of the Global Fund is – Partnership;
Country ownership; Performance-based findings, transparency.
The Country Coordinating Mechanism is unique approach advocated
by the Global Fund. Countries take the lead in determining where and
how best to fight diseases, how to respond to broader development
challenges, and how to coordinate work with international partners
in global health.
The pre-board meeting introduces the delegates of the agendas of the
upcoming Global Fund meeting in Skopje, Macedonia
It will assist the Board Member ti arrive at a regional response to the
agenda points in consultation with delegates and convey the same at
the board meeting
Global Fund support is critical to achieve the global and regional
targets of ending the three diseases
The Global Fund since inception has invested over USD 4 billion in
the Region (52% for HIV; 30% for TB and 17% for malaria).
Global Fund during the current period of 2017-19 has made an
allocation of USD 1.3 billion for countries in the region except
Maldives (not eligible for GF due to national income status).
Page 26 of 29
The South-East Asia Region has high burden of TB, Malaria and HIV.
However, with high national commitments and strong responses,
great public health achievements have been made in the Region.
Malaria has been eliminated in Sri Lanka and Maldives. Two other
countries are moving towards elimination Bhutan and Timor-Leste.
57% decline in new HIV infections since 2001 and 43% declines in
deaths
Treat all approach has been adopted by all countries
Thailand has eliminated Mother to child transmission of HIV
About 15-20% decline in new TB cases in last decade
High level political commitment to end TB in the Region as
demonstrated by the 2017 Ministerial meeting and the Delhi Summit
this year. Upcoming High-Level Meeting at the United Nations
However, much need to be done going forward including integrated,
quality assured service delivery through the UHC approach
Bridging the funding gaps. For TB along it is about USD 1.3 billion
each year
Role of the Global Fund will be important both in supporting high
disease burden or have reach elimination targets.
We expect the SEA Constituency Board Leadership to emphasis on
the Global Fund to nor let political agendas undermine public health
agendas
The WHO SEA Regional Office is committed to support the
Constituency and Member States
I wish you all a very productive meeting and comfortable stay in
Delhi.
Page 27 of 29
Opening Remarks by Dr. Marijke Wijnroks, Chief of Staff, GF Inaugural session of SEA constituency Meeting
23rd April 2018, Nirman Bhawan
Greetings and thank you to the constituency, to our hosts, and to all
who prepared and facilitated the arrangements for this meeting.
Particular thanks to our gracious host, the Honorable Secretary of
Health of India, who so kindly made time available in her busy
schedule, to Filipe Da Costa, Board Member and Chair of the
Implementer Group; Dr Md. Serajul Huq Khanthe, Alternate Board
Member; and to the CCM Secretariat of India, WHO; and the
International Institute of Health Management Research.
Welcome the opportunity to participate in the constituency’s pre-
Board meeting and to engage with delegates on this occasion.
It is really good to be back in this region that I know so well, and I
would like to note the strategic significance of the national and
regional portfolios in South East Asia, to which Swarup already
alluded. This region has some of our largest portfolios, and in many
areas, you have achieved impressive results. You also have great
opportunities; this region is in a good position to eliminate malaria
and you can shift the global needle on Tuberculosis. Here in India, the
political commitment of PM Modi, and a commitment at all levels to
eliminate TB by 2025, is truly remarkable. I hope this level of political
commitment will be an inspiration to the region. What you are doing
and the results you achieve matter a lot for global health.
We have a significant Board meeting ahead of us in May. As always,
the agenda is a busy one, with decisions of strategic significance as
we work together to successfully pursue our Strategic Objectives, and
our collective mission to end the epidemics.
Of particular note, the Board will consider:
o revisions to the Eligibility Policy;
o a Risk Appetite Framework to guide informed decision-making
with respect to appropriate (higher or lower) levels of risks, to
realize Board-approved strategic objectives; and
Page 28 of 29
o a way forward for the CCM Evolution initiative, aimed at
strengthening the role of CCMs to align with the Global Fund
Strategy, enabling a differentiated approach, enhancing CCM
performance, and facilitating evolution in CCM maturity.
This is also an important Board meeting for Global Fund governance,
as the Board considers a proposal to strengthen the process to select
and appoint the Board Chair and Vice Chair. With Felipe serving as
both Board Member and Chair of the Implementer Group, we
particularly welcome the South East Asia constituency’s engagement,
input and support to this initiative.
The proposal on Board Leadership selection reflects a broader
ambition of the Board Chair and Vice-Chair of moving increasingly
towards “one Board”, a Board which reflects the evolving global
health landscape, pursuing our collective mission. India is a perfect
illustration of a changed reality, as it is an implementer as well as a
donor to the Global Fund.
We will have the opportunity to look more closely at the items
coming to the Board over the course of the meeting, and I remain
available to respond to your queries as you consider the important
matters under Board consideration.
Finally, underline the value of constituency meetings. This is a
welcome opportunity for representatives from across the region to
convene, in advance of the Board Meeting, to take time to engage on
key strategic matters. A well functioning constituency is of critical
importance for the region, making sure that you are well
represented, your concerns heard and your insights shared. Filipe
told me that you will discuss changes to the process of selecting your
board representation in your next meeting. Along with WHO SEARO,
and I very much appreciate all the support they have given to the
constituency, we stand ready to support you in that process.
In this context, wish the constituency a fruitful and successful
meeting, and reiterate thanks for the invitation to join the meeting.
(Annexure continued in separate file)
